Showing results (1501-1510 of 1,715) with videos related to

Sort By:
Pageof 172
Molecular Endocrinology (Baltimore, Md.)|August 29, 2002
Persistent parity-induced changes in growth factors, TGF-beta3, and differentiation in the rodent mammary glandCelina M D'Cruz, Susan E Moody, Stephen R Master, et al.
International Journal of Radiation Oncology, Biology, Physics|April 8, 2011
Intensity-modulated proton therapy further reduces normal tissue exposure during definitive therapy for locally advanced distal esophageal tumors: a dosimetric studyJames Welsh, Daniel Gomez, Matthew B Palmer, et al.
The American Journal of Cardiology|January 12, 2001
Final results of a randomized trial comparing the MULTI-LINK stent with the Palmaz-Schatz stent for narrowings in native coronary arteriesD S Baim, D E Cutlip, M Midei, et al.
Diabetologia|February 25, 2005
A genetic and physiological study of impaired glucose homeostasis control in C57BL/6J miceA A Toye, J D Lippiat, P Proks, et al.
Practical Radiation Oncology|November 20, 2014
Evaluation and mitigation of the interplay effects of intensity modulated proton therapy for lung cancer in a clinical settingLaleh Kardar, Yupeng Li, Xiaoqiang Li, et al.
JCI Insight|October 20, 2017
Cinacalcet corrects hypercalcemia in mice with an inactivating Gα11 mutationSarah A Howles, Fadil M Hannan, Caroline M Gorvin, et al.
Medical Physics|February 11, 2014
On the interplay effects with proton scanning beams in stage III lung cancerYupeng Li, Laleh Kardar, Xiaoqiang Li, et al.
Kidney International|December 25, 2025
Sodium-glucose co-transporter 2 inhibition improves age-dependent kidney microvascular rarefactionAnastasia Paulmann, Matthew D Cox, Tom Boewer, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|February 1, 2017
Long-term outcome of phase I/II prospective study of dose-escalated proton therapy for early-stage non-small cell lung cancerJoe Y Chang, Wencheng Zhang, Ritsuko Komaki, et al.
Plos Genetics|August 15, 2009
A mouse model for the metabolic effects of the human fat mass and obesity associated FTO geneChris Church, Sheena Lee, Eleanor A L Bagg, et al.
Pageof 172